Frankfurt - Delayed Quote EUR
Cellectar Biosciences, Inc. (NV4.F)
0.2480
+0.0020
+(0.81%)
At close: April 25 at 3:49:30 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
25,474.0470
12,075.5800
21,589.7900
37,201.8090
Total Liabilities Net Minority Interest
11,179.3660
27,234.5480
13,436.5460
4,156.6550
Total Equity Gross Minority Interest
14,294.6810
-15,158.9680
8,153.2440
33,045.1540
Total Capitalization
14,294.6810
-15,158.9680
8,153.2440
33,045.1540
Preferred Stock Equity
520.7780
4,677.6320
1,382.0230
1,382.0230
Common Stock Equity
13,773.9030
-19,836.6000
8,153.2440
31,663.1310
Capital Lease Obligations
494.0030
552.9820
603.8280
301.7410
Net Tangible Assets
14,294.6810
-15,158.9680
8,153.2440
33,045.1540
Working Capital
14,862.5150
-14,905.3090
9,028.0590
32,581.0970
Invested Capital
13,773.9030
-19,836.6000
8,153.2440
31,663.1310
Tangible Book Value
13,773.9030
-19,836.6000
8,153.2440
31,663.1310
Total Debt
494.0030
552.9820
603.8280
301.7410
Share Issued
46,079.8760
20,744.1100
9,385.2720
6,110.1260
Ordinary Shares Number
46,079.8760
20,744.1100
9,385.2720
6,110.1260
Preferred Shares Number
--
--
0.2040
--
12/31/2021 - 12/8/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade